EcoDrugPlus

Cholecystokinin Receptor

Ensembl ID : ENSOKIG00005025624
Gene Symbol: LOC109890455
3 Cross references
187 Possible Orthologues:

Cholesterol 24-Hydroxylase

Ensembl ID : ENSOKIG00005013039
Gene Symbol: LOC109866694
2 Cross references
240 Possible Orthologues:

Cholesterol 24-Hydroxylase-Like

Ensembl ID : ENSOKIG00005039455
Gene Symbol: LOC109901317
2 Cross references
242 Possible Orthologues:

Cholesterol 24-Hydroxylase-Like

Ensembl ID : ENSOKIG00005039927
Gene Symbol: LOC109900504
2 Cross references
238 Possible Orthologues:

Cholesterol 24-Hydroxylase-Like

Ensembl ID : ENSOKIG00005041128
Gene Symbol: LOC109901319
2 Cross references
243 Possible Orthologues:

Cholesterol 24-Hydroxylase-Like

Ensembl ID : ENSOKIG00005039544
Gene Symbol: LOC109900502
2 Cross references
240 Possible Orthologues:

Cholesteryl Ester Transfer Protein

Ensembl ID : ENSOKIG00005022284
Gene Symbol: CETP
3 Cross references
132 Possible Orthologues:

Cholesteryl Ester Transfer Protein, Plasma

Ensembl ID : ENSOKIG00005001018
Gene Symbol: CETP
1 Cross references
131 Possible Orthologues:

Cholinergic Receptor Muscarinic 3

Ensembl ID : ENSOKIG00005043026
Gene Symbol: CHRM3
3 Cross references
181 Possible Orthologues:

Cholinergic Receptor Muscarinic 3

Ensembl ID : ENSOKIG00005034320
Gene Symbol: CHRM3
3 Cross references
182 Possible Orthologues:

Cholinergic Receptor Muscarinic 3

Ensembl ID : ENSOKIG00005048997
Gene Symbol: CHRM3
1 Cross references
183 Possible Orthologues:

Cholinergic Receptor Muscarinic 4

Ensembl ID : ENSOKIG00005007520
Gene Symbol: CHRM4
3 Cross references
181 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).